September 29, 2019
ESMO Sept 29 Unravelling the biological characteristics of MammaPrint
Rajith Bhaskaran, Christian J Griffioen, Diedrik Wehkamp, Lorenza Mittempergher and Annuska M Glas
Unravelling the biological characteristics of MammaPrint extreme risk subgroups
MammaPrint®(MP) is a 70-gene based prognostic assay that stratifies early-stage breast cancer patients into low and high-risk of relapse. Recently, further stratification of the 70-gene risk results identified extreme low and high-risk subgroups with specific clinical outcomes (Delahaye et al. 2017) and treatment response characteristics (Wolf et al. 2017).